Steven Edmundowicz
Concepts (470)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cholangiopancreatography, Endoscopic Retrograde | 38 | 2025 | 204 | 4.000 |
Why?
| Endoscopy, Gastrointestinal | 29 | 2023 | 215 | 3.830 |
Why?
| Endosonography | 29 | 2023 | 141 | 2.150 |
Why?
| Bariatric Surgery | 12 | 2019 | 190 | 1.950 |
Why?
| Esophageal Neoplasms | 13 | 2022 | 297 | 1.840 |
Why?
| Endoscopy, Digestive System | 16 | 2021 | 120 | 1.830 |
Why?
| Pancreatic Neoplasms | 20 | 2023 | 878 | 1.740 |
Why?
| Endoscopy | 13 | 2020 | 268 | 1.570 |
Why?
| Adenoma | 12 | 2023 | 210 | 1.570 |
Why?
| Weight Loss | 11 | 2019 | 723 | 1.440 |
Why?
| Gastric Balloon | 6 | 2018 | 16 | 1.410 |
Why?
| Obesity | 17 | 2019 | 2844 | 1.390 |
Why?
| Gastroplasty | 5 | 2019 | 29 | 1.320 |
Why?
| Pancreatitis | 13 | 2024 | 129 | 1.240 |
Why?
| Gastrointestinal Hemorrhage | 4 | 2019 | 117 | 1.190 |
Why?
| Adenocarcinoma | 13 | 2023 | 895 | 1.190 |
Why?
| Barrett Esophagus | 10 | 2022 | 149 | 1.130 |
Why?
| Stents | 18 | 2024 | 518 | 1.120 |
Why?
| Stomach Neoplasms | 5 | 2020 | 97 | 1.100 |
Why?
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 9 | 2019 | 54 | 1.070 |
Why?
| Colonic Neoplasms | 6 | 2015 | 234 | 1.060 |
Why?
| Pancreatic Ducts | 10 | 2024 | 80 | 1.020 |
Why?
| Drainage | 11 | 2023 | 162 | 0.990 |
Why?
| Gastroenterology | 10 | 2019 | 177 | 0.970 |
Why?
| Colonoscopy | 12 | 2023 | 225 | 0.960 |
Why?
| Colonic Polyps | 7 | 2015 | 86 | 0.960 |
Why?
| Gastroesophageal Reflux | 11 | 2020 | 240 | 0.900 |
Why?
| Bile Duct Neoplasms | 4 | 2020 | 99 | 0.850 |
Why?
| Gastrointestinal Diseases | 4 | 2022 | 197 | 0.750 |
Why?
| Cholestasis | 3 | 2020 | 229 | 0.750 |
Why?
| Duodenum | 4 | 2019 | 69 | 0.710 |
Why?
| Duodenoscopes | 2 | 2020 | 7 | 0.710 |
Why?
| Esophagus | 8 | 2019 | 253 | 0.680 |
Why?
| Obesity, Morbid | 7 | 2019 | 241 | 0.670 |
Why?
| Humans | 159 | 2025 | 128896 | 0.670 |
Why?
| Pancreatic Diseases | 6 | 2023 | 67 | 0.660 |
Why?
| Middle Aged | 91 | 2025 | 30977 | 0.660 |
Why?
| Biliary Tract Neoplasms | 1 | 2019 | 25 | 0.660 |
Why?
| Biopsy, Fine-Needle | 8 | 2017 | 66 | 0.640 |
Why?
| Clinical Competence | 11 | 2020 | 1020 | 0.630 |
Why?
| Catheterization | 9 | 2024 | 176 | 0.630 |
Why?
| Pancreatic Pseudocyst | 4 | 2018 | 13 | 0.610 |
Why?
| Aged | 70 | 2025 | 22035 | 0.600 |
Why?
| Cross Infection | 1 | 2020 | 203 | 0.590 |
Why?
| Indomethacin | 3 | 2024 | 78 | 0.580 |
Why?
| Learning Curve | 6 | 2019 | 68 | 0.570 |
Why?
| Endoscopic Mucosal Resection | 5 | 2022 | 22 | 0.570 |
Why?
| Radiation Exposure | 1 | 2017 | 48 | 0.560 |
Why?
| Gastrostomy | 5 | 2019 | 113 | 0.560 |
Why?
| Intestine, Small | 2 | 2020 | 140 | 0.550 |
Why?
| Colonic Diseases | 3 | 2013 | 31 | 0.540 |
Why?
| Radiation Injuries | 1 | 2017 | 139 | 0.530 |
Why?
| Prospective Studies | 35 | 2023 | 7060 | 0.530 |
Why?
| Jejunum | 2 | 2015 | 29 | 0.530 |
Why?
| Treatment Outcome | 35 | 2025 | 10239 | 0.500 |
Why?
| Self Expandable Metallic Stents | 3 | 2022 | 14 | 0.500 |
Why?
| Pathology, Clinical | 1 | 2015 | 31 | 0.490 |
Why?
| Smell | 1 | 2016 | 132 | 0.490 |
Why?
| Male | 92 | 2025 | 63146 | 0.490 |
Why?
| Pancreas | 7 | 2021 | 307 | 0.480 |
Why?
| Gastrointestinal Neoplasms | 2 | 2013 | 72 | 0.480 |
Why?
| Cholelithiasis | 8 | 2010 | 34 | 0.480 |
Why?
| Pancreatitis, Chronic | 4 | 2022 | 51 | 0.480 |
Why?
| Laparoscopy | 6 | 2020 | 452 | 0.470 |
Why?
| Female | 94 | 2025 | 68162 | 0.470 |
Why?
| Suction | 2 | 2017 | 32 | 0.460 |
Why?
| Catheter Ablation | 5 | 2022 | 324 | 0.450 |
Why?
| Postoperative Hemorrhage | 3 | 2017 | 85 | 0.440 |
Why?
| Esophagoscopy | 8 | 2022 | 196 | 0.440 |
Why?
| Postoperative Complications | 11 | 2024 | 2494 | 0.440 |
Why?
| Gallstones | 6 | 1996 | 30 | 0.430 |
Why?
| Lithotripsy | 5 | 2019 | 43 | 0.420 |
Why?
| Propofol | 4 | 2023 | 55 | 0.400 |
Why?
| Sensitivity and Specificity | 11 | 2019 | 1840 | 0.400 |
Why?
| Adult | 59 | 2025 | 35361 | 0.400 |
Why?
| Body Weight | 1 | 2016 | 931 | 0.390 |
Why?
| Diabetes Mellitus, Type 2 | 2 | 2017 | 2421 | 0.380 |
Why?
| Colorectal Neoplasms | 5 | 2022 | 730 | 0.370 |
Why?
| Aged, 80 and over | 23 | 2025 | 7050 | 0.370 |
Why?
| Biopsy | 5 | 2019 | 1093 | 0.370 |
Why?
| Precancerous Conditions | 4 | 2017 | 164 | 0.370 |
Why?
| Gastroscopy | 4 | 2014 | 18 | 0.370 |
Why?
| Quality Indicators, Health Care | 5 | 2018 | 299 | 0.360 |
Why?
| Bile Ducts | 5 | 2014 | 66 | 0.350 |
Why?
| Duodenal Neoplasms | 2 | 2023 | 22 | 0.340 |
Why?
| Ampulla of Vater | 3 | 2023 | 39 | 0.340 |
Why?
| Pancreatic Cyst | 3 | 2018 | 53 | 0.340 |
Why?
| Cytodiagnosis | 2 | 2020 | 32 | 0.340 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2024 | 339 | 0.340 |
Why?
| Pancreatitis, Acute Necrotizing | 3 | 2023 | 12 | 0.330 |
Why?
| Insufflation | 1 | 2009 | 9 | 0.330 |
Why?
| Constriction, Pathologic | 6 | 2022 | 230 | 0.320 |
Why?
| In Situ Hybridization, Fluorescence | 2 | 2020 | 319 | 0.310 |
Why?
| Common Bile Duct Neoplasms | 2 | 2023 | 27 | 0.310 |
Why?
| Retrospective Studies | 35 | 2025 | 14546 | 0.310 |
Why?
| Esophagogastric Junction | 3 | 2019 | 48 | 0.310 |
Why?
| Cholecystectomy, Laparoscopic | 6 | 2008 | 51 | 0.300 |
Why?
| Calculi | 3 | 2019 | 16 | 0.280 |
Why?
| Decompression, Surgical | 2 | 2023 | 97 | 0.280 |
Why?
| Pain, Postoperative | 1 | 2009 | 227 | 0.280 |
Why?
| Carbon Dioxide | 1 | 2009 | 261 | 0.280 |
Why?
| Gastrointestinal Stromal Tumors | 3 | 2015 | 46 | 0.270 |
Why?
| Sphincterotomy, Endoscopic | 6 | 2019 | 26 | 0.270 |
Why?
| Prosthesis Implantation | 3 | 2019 | 149 | 0.270 |
Why?
| Pancreatectomy | 2 | 2021 | 245 | 0.260 |
Why?
| Endoscopes, Gastrointestinal | 1 | 2006 | 12 | 0.260 |
Why?
| Body Mass Index | 7 | 2019 | 2244 | 0.260 |
Why?
| Thoracoscopy | 1 | 2006 | 52 | 0.260 |
Why?
| Neoplasm Recurrence, Local | 4 | 2023 | 952 | 0.250 |
Why?
| Follow-Up Studies | 16 | 2015 | 4917 | 0.250 |
Why?
| Neuroendocrine Tumors | 2 | 2018 | 100 | 0.250 |
Why?
| Early Detection of Cancer | 5 | 2022 | 349 | 0.240 |
Why?
| Mental Recall | 1 | 2006 | 185 | 0.240 |
Why?
| Societies, Medical | 3 | 2018 | 760 | 0.230 |
Why?
| Esophageal Sphincter, Lower | 2 | 2015 | 11 | 0.230 |
Why?
| Polyvinyls | 1 | 2004 | 19 | 0.230 |
Why?
| Magnets | 2 | 2015 | 19 | 0.230 |
Why?
| Plastics | 3 | 2022 | 45 | 0.220 |
Why?
| Gastric Bypass | 2 | 2017 | 106 | 0.220 |
Why?
| Periodicals as Topic | 1 | 2006 | 209 | 0.210 |
Why?
| Ablation Techniques | 3 | 2017 | 31 | 0.210 |
Why?
| Common Bile Duct | 3 | 2009 | 15 | 0.210 |
Why?
| Internet | 2 | 2009 | 616 | 0.200 |
Why?
| Gastrointestinal Tract | 1 | 2025 | 182 | 0.200 |
Why?
| Patient Satisfaction | 1 | 2006 | 639 | 0.200 |
Why?
| Fluoroscopy | 3 | 2019 | 167 | 0.200 |
Why?
| Prostheses and Implants | 3 | 2013 | 140 | 0.190 |
Why?
| Anesthesia | 1 | 2023 | 130 | 0.190 |
Why?
| Pneumonia, Aspiration | 2 | 2019 | 17 | 0.190 |
Why?
| Carcinoma, Pancreatic Ductal | 3 | 2017 | 264 | 0.190 |
Why?
| Deglutition Disorders | 3 | 2019 | 129 | 0.180 |
Why?
| Intestinal Perforation | 2 | 2018 | 44 | 0.180 |
Why?
| Carcinoembryonic Antigen | 3 | 2018 | 42 | 0.180 |
Why?
| Prosthesis Design | 3 | 2019 | 321 | 0.180 |
Why?
| Double-Blind Method | 7 | 2018 | 1858 | 0.180 |
Why?
| Logistic Models | 7 | 2024 | 1963 | 0.180 |
Why?
| Varicose Veins | 1 | 2020 | 17 | 0.170 |
Why?
| Esophageal and Gastric Varices | 1 | 2020 | 35 | 0.170 |
Why?
| Neoplasm Staging | 5 | 2017 | 1285 | 0.170 |
Why?
| Biliary Tract Diseases | 4 | 2014 | 36 | 0.170 |
Why?
| Deep Sedation | 2 | 2010 | 12 | 0.170 |
Why?
| Quality of Life | 10 | 2019 | 2706 | 0.170 |
Why?
| Cell-Free System | 1 | 2019 | 48 | 0.170 |
Why?
| Abdominal Pain | 3 | 2019 | 144 | 0.170 |
Why?
| Equipment Design | 6 | 2020 | 522 | 0.170 |
Why?
| Fiducial Markers | 1 | 2019 | 8 | 0.160 |
Why?
| Urinary Calculi | 1 | 2019 | 11 | 0.160 |
Why?
| Risk Factors | 13 | 2024 | 9792 | 0.160 |
Why?
| Watchful Waiting | 3 | 2019 | 66 | 0.160 |
Why?
| Radiotherapy, Image-Guided | 1 | 2019 | 32 | 0.160 |
Why?
| Academic Medical Centers | 3 | 2023 | 473 | 0.160 |
Why?
| Needles | 1 | 2019 | 57 | 0.160 |
Why?
| Practice Guidelines as Topic | 2 | 2018 | 1523 | 0.160 |
Why?
| Infection Control | 1 | 2020 | 138 | 0.160 |
Why?
| Liver Neoplasms | 1 | 2023 | 637 | 0.150 |
Why?
| Esophageal Stenosis | 1 | 2019 | 51 | 0.150 |
Why?
| Metals | 4 | 2023 | 126 | 0.150 |
Why?
| Abdomen | 2 | 2016 | 116 | 0.150 |
Why?
| Administration, Rectal | 3 | 2024 | 11 | 0.150 |
Why?
| Reproducibility of Results | 7 | 2020 | 3042 | 0.150 |
Why?
| Cystadenoma, Serous | 1 | 2018 | 17 | 0.150 |
Why?
| Simulation Training | 1 | 2019 | 80 | 0.140 |
Why?
| Delayed Diagnosis | 1 | 2018 | 81 | 0.140 |
Why?
| Obesity Management | 1 | 2017 | 8 | 0.140 |
Why?
| Cystadenoma, Mucinous | 2 | 2015 | 13 | 0.140 |
Why?
| Aneurysm, False | 1 | 2018 | 46 | 0.140 |
Why?
| Cystadenocarcinoma, Mucinous | 2 | 2015 | 14 | 0.140 |
Why?
| Suture Techniques | 3 | 2017 | 120 | 0.140 |
Why?
| Conscious Sedation | 2 | 2023 | 84 | 0.140 |
Why?
| Education, Medical, Graduate | 2 | 2019 | 436 | 0.140 |
Why?
| Pancreaticoduodenectomy | 2 | 2016 | 159 | 0.140 |
Why?
| Insurance, Health, Reimbursement | 1 | 2017 | 94 | 0.140 |
Why?
| Diagnostic Tests, Routine | 1 | 2018 | 101 | 0.140 |
Why?
| Calcinosis | 1 | 2019 | 255 | 0.140 |
Why?
| Metaplasia | 4 | 2022 | 54 | 0.130 |
Why?
| Diet Therapy | 1 | 2016 | 37 | 0.130 |
Why?
| Immunoassay | 1 | 2017 | 101 | 0.130 |
Why?
| Polymerase Chain Reaction | 1 | 2019 | 1045 | 0.130 |
Why?
| Population Surveillance | 2 | 2017 | 428 | 0.130 |
Why?
| Young Adult | 11 | 2025 | 12286 | 0.130 |
Why?
| Stomach | 1 | 2016 | 109 | 0.130 |
Why?
| Respiratory Insufficiency | 2 | 2010 | 316 | 0.130 |
Why?
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 25 | 0.130 |
Why?
| Referral and Consultation | 3 | 2019 | 727 | 0.130 |
Why?
| Bariatric Medicine | 1 | 2015 | 2 | 0.130 |
Why?
| Intestinal Mucosa | 3 | 2017 | 569 | 0.130 |
Why?
| Intubation, Gastrointestinal | 1 | 1996 | 76 | 0.130 |
Why?
| Single-Blind Method | 5 | 2019 | 273 | 0.120 |
Why?
| Fellowships and Scholarships | 1 | 2019 | 271 | 0.120 |
Why?
| Dogs | 1 | 2016 | 372 | 0.120 |
Why?
| Life Style | 2 | 2018 | 459 | 0.120 |
Why?
| Colon, Ascending | 1 | 2015 | 3 | 0.120 |
Why?
| Pilot Projects | 2 | 2013 | 1545 | 0.120 |
Why?
| Documentation | 1 | 2017 | 182 | 0.120 |
Why?
| Dissection | 1 | 2015 | 55 | 0.120 |
Why?
| Neoplasms, Multiple Primary | 1 | 2015 | 55 | 0.120 |
Why?
| Cholecystectomy | 4 | 2009 | 60 | 0.120 |
Why?
| Peristalsis | 2 | 1991 | 30 | 0.120 |
Why?
| Proton Pump Inhibitors | 3 | 2020 | 103 | 0.120 |
Why?
| Aptitude | 1 | 2014 | 38 | 0.110 |
Why?
| Colorectal Surgery | 1 | 2014 | 22 | 0.110 |
Why?
| Leiomyoma | 1 | 2015 | 73 | 0.110 |
Why?
| Ulcer | 1 | 2014 | 28 | 0.110 |
Why?
| Multivariate Analysis | 4 | 2021 | 1504 | 0.110 |
Why?
| Biomarkers, Tumor | 3 | 2017 | 1170 | 0.110 |
Why?
| Colectomy | 1 | 2014 | 94 | 0.110 |
Why?
| Liver Cirrhosis | 2 | 2020 | 274 | 0.110 |
Why?
| Hemorrhage | 1 | 2018 | 658 | 0.110 |
Why?
| Predictive Value of Tests | 6 | 2016 | 1967 | 0.110 |
Why?
| Patient Safety | 1 | 2016 | 292 | 0.110 |
Why?
| Cholangiopancreatography, Magnetic Resonance | 1 | 2013 | 17 | 0.110 |
Why?
| Anastomosis, Roux-en-Y | 1 | 2013 | 27 | 0.110 |
Why?
| Multidetector Computed Tomography | 1 | 2013 | 33 | 0.100 |
Why?
| Ultrasonography, Interventional | 2 | 2015 | 139 | 0.100 |
Why?
| Community Health Services | 1 | 2014 | 224 | 0.100 |
Why?
| Contrast Media | 1 | 1995 | 387 | 0.100 |
Why?
| Recurrence | 4 | 2020 | 1013 | 0.100 |
Why?
| Bile Duct Diseases | 1 | 2012 | 14 | 0.100 |
Why?
| Exercise Therapy | 1 | 2016 | 406 | 0.100 |
Why?
| Cholecystitis | 1 | 1992 | 23 | 0.100 |
Why?
| Health Care Costs | 1 | 2015 | 404 | 0.100 |
Why?
| Risk Assessment | 8 | 2016 | 3286 | 0.100 |
Why?
| Lymph Nodes | 2 | 2012 | 458 | 0.100 |
Why?
| Cholestasis, Extrahepatic | 1 | 1991 | 4 | 0.100 |
Why?
| Diverticulum | 1 | 1991 | 11 | 0.100 |
Why?
| Duodenal Diseases | 1 | 1991 | 8 | 0.100 |
Why?
| Digestive System Diseases | 1 | 2011 | 25 | 0.100 |
Why?
| Diagnosis, Differential | 6 | 2015 | 1435 | 0.090 |
Why?
| Esophageal Diseases | 1 | 1991 | 27 | 0.090 |
Why?
| Sensation | 1 | 1991 | 49 | 0.090 |
Why?
| Time Factors | 8 | 2019 | 6568 | 0.090 |
Why?
| Chest Pain | 1 | 1991 | 89 | 0.090 |
Why?
| Patient Compliance | 1 | 2015 | 563 | 0.090 |
Why?
| Proteomics | 1 | 2017 | 985 | 0.090 |
Why?
| Deglutition | 1 | 1991 | 66 | 0.090 |
Why?
| Severity of Illness Index | 1 | 2019 | 2767 | 0.090 |
Why?
| Hypotension | 1 | 2011 | 118 | 0.090 |
Why?
| Image Enhancement | 1 | 2011 | 165 | 0.090 |
Why?
| United States | 10 | 2018 | 13975 | 0.090 |
Why?
| Hepatic Duct, Common | 1 | 2010 | 6 | 0.090 |
Why?
| Muscle, Smooth | 1 | 1991 | 151 | 0.090 |
Why?
| Colonoscopes | 1 | 2009 | 5 | 0.090 |
Why?
| Bile | 1 | 2009 | 27 | 0.080 |
Why?
| Cholecystostomy | 1 | 1989 | 4 | 0.080 |
Why?
| Disease Progression | 5 | 2017 | 2603 | 0.080 |
Why?
| Odds Ratio | 4 | 2016 | 1019 | 0.080 |
Why?
| Sleep Apnea Syndromes | 1 | 2010 | 78 | 0.080 |
Why?
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2010 | 73 | 0.080 |
Why?
| Anesthetics | 1 | 2009 | 55 | 0.080 |
Why?
| Abdominal Neoplasms | 1 | 2009 | 32 | 0.080 |
Why?
| Loss of Heterozygosity | 1 | 2009 | 44 | 0.080 |
Why?
| Tumor Burden | 3 | 2015 | 284 | 0.080 |
Why?
| Equipment Safety | 2 | 2009 | 40 | 0.080 |
Why?
| Intestinal Obstruction | 1 | 2009 | 48 | 0.080 |
Why?
| Adolescent | 8 | 2025 | 20197 | 0.080 |
Why?
| Mutation | 1 | 2019 | 3671 | 0.080 |
Why?
| DNA, Neoplasm | 1 | 2009 | 162 | 0.080 |
Why?
| Cholangiography | 1 | 2008 | 17 | 0.080 |
Why?
| Choledocholithiasis | 1 | 2008 | 14 | 0.070 |
Why?
| Incidence | 5 | 2018 | 2634 | 0.070 |
Why?
| Video Recording | 3 | 2014 | 161 | 0.070 |
Why?
| Feeding Behavior | 1 | 2013 | 620 | 0.070 |
Why?
| Ultrasonography | 4 | 1996 | 727 | 0.070 |
Why?
| Quality Assurance, Health Care | 1 | 2010 | 319 | 0.070 |
Why?
| Health Services Research | 1 | 2010 | 392 | 0.070 |
Why?
| Positron-Emission Tomography | 1 | 2008 | 284 | 0.070 |
Why?
| Acute Disease | 4 | 2008 | 978 | 0.070 |
Why?
| Biopsy, Needle | 2 | 2004 | 191 | 0.070 |
Why?
| Registries | 1 | 2015 | 1916 | 0.070 |
Why?
| Hyperplasia | 2 | 2019 | 171 | 0.060 |
Why?
| Pleural Diseases | 1 | 2006 | 18 | 0.060 |
Why?
| Research Design | 2 | 2016 | 1038 | 0.060 |
Why?
| Pancreatic Fistula | 1 | 2006 | 26 | 0.060 |
Why?
| Prognosis | 5 | 2017 | 3787 | 0.060 |
Why?
| Delphi Technique | 2 | 2017 | 219 | 0.060 |
Why?
| Pain | 2 | 2022 | 761 | 0.060 |
Why?
| Cohort Studies | 5 | 2020 | 5394 | 0.060 |
Why?
| Hospital Units | 1 | 2004 | 22 | 0.060 |
Why?
| Health Care Surveys | 3 | 2014 | 560 | 0.060 |
Why?
| Hypoxia | 1 | 2011 | 1070 | 0.060 |
Why?
| Surveys and Questionnaires | 4 | 2015 | 5355 | 0.060 |
Why?
| Cyst Fluid | 2 | 2018 | 27 | 0.060 |
Why?
| Tertiary Care Centers | 2 | 2016 | 147 | 0.060 |
Why?
| Diphenhydramine | 1 | 2023 | 31 | 0.050 |
Why?
| Midazolam | 1 | 2023 | 49 | 0.050 |
Why?
| Efficiency, Organizational | 1 | 2004 | 131 | 0.050 |
Why?
| Carcinoma, Squamous Cell | 1 | 2008 | 626 | 0.050 |
Why?
| Observer Variation | 2 | 2014 | 321 | 0.050 |
Why?
| Missouri | 2 | 2014 | 66 | 0.050 |
Why?
| Disposable Equipment | 2 | 2009 | 20 | 0.050 |
Why?
| Fentanyl | 1 | 2023 | 78 | 0.050 |
Why?
| Electrocoagulation | 1 | 2023 | 37 | 0.050 |
Why?
| Mass Screening | 1 | 2010 | 1121 | 0.050 |
Why?
| Animals | 3 | 2020 | 34628 | 0.050 |
Why?
| Hypnotics and Sedatives | 1 | 2023 | 158 | 0.050 |
Why?
| Neoplasms | 1 | 2016 | 2426 | 0.050 |
Why?
| Necrosis | 1 | 2023 | 234 | 0.050 |
Why?
| Esophagitis, Peptic | 1 | 2002 | 17 | 0.050 |
Why?
| Guidelines as Topic | 2 | 2015 | 259 | 0.050 |
Why?
| Tomography, X-Ray Computed | 3 | 2006 | 2530 | 0.050 |
Why?
| Endoscopes | 2 | 1998 | 18 | 0.050 |
Why?
| Cholestasis, Intrahepatic | 1 | 2001 | 38 | 0.050 |
Why?
| Bile Ducts, Intrahepatic | 1 | 2001 | 65 | 0.050 |
Why?
| Lumbar Vertebrae | 1 | 2023 | 217 | 0.050 |
Why?
| Hyperthermia, Induced | 1 | 2002 | 107 | 0.040 |
Why?
| Silicones | 1 | 2020 | 22 | 0.040 |
Why?
| Length of Stay | 4 | 2018 | 1126 | 0.040 |
Why?
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2000 | 40 | 0.040 |
Why?
| Combined Modality Therapy | 2 | 2016 | 1213 | 0.040 |
Why?
| Hemostatic Techniques | 1 | 2000 | 46 | 0.040 |
Why?
| Los Angeles | 1 | 2020 | 62 | 0.040 |
Why?
| Feasibility Studies | 2 | 2018 | 859 | 0.040 |
Why?
| Fundoplication | 1 | 2020 | 54 | 0.040 |
Why?
| Technology Assessment, Biomedical | 5 | 1998 | 31 | 0.040 |
Why?
| Contraindications | 2 | 2017 | 90 | 0.040 |
Why?
| Equivalence Trials as Topic | 1 | 2019 | 7 | 0.040 |
Why?
| Microscopy, Confocal | 1 | 2020 | 308 | 0.040 |
Why?
| Clinical Trials as Topic | 2 | 2015 | 1002 | 0.040 |
Why?
| General Surgery | 1 | 2000 | 156 | 0.040 |
Why?
| Adenocarcinoma, Mucinous | 2 | 2009 | 72 | 0.040 |
Why?
| Probability | 2 | 2009 | 313 | 0.040 |
Why?
| Resuscitation | 1 | 2000 | 244 | 0.040 |
Why?
| Radiology | 1 | 2000 | 160 | 0.040 |
Why?
| Electrodes | 1 | 1998 | 103 | 0.040 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2006 | 1264 | 0.040 |
Why?
| Electrosurgery | 1 | 1998 | 43 | 0.040 |
Why?
| Swine | 1 | 2020 | 740 | 0.040 |
Why?
| Reference Standards | 1 | 2018 | 168 | 0.040 |
Why?
| Practice Patterns, Physicians' | 3 | 2014 | 1281 | 0.040 |
Why?
| Systemic Inflammatory Response Syndrome | 1 | 2018 | 84 | 0.040 |
Why?
| Surgical Instruments | 1 | 2018 | 52 | 0.040 |
Why?
| Statistics, Nonparametric | 2 | 2008 | 424 | 0.030 |
Why?
| Granulation Tissue | 1 | 2016 | 5 | 0.030 |
Why?
| Manometry | 2 | 2001 | 92 | 0.030 |
Why?
| Minimally Invasive Surgical Procedures | 2 | 2008 | 172 | 0.030 |
Why?
| Organizational Policy | 1 | 2017 | 76 | 0.030 |
Why?
| Patient Admission | 1 | 2018 | 185 | 0.030 |
Why?
| Surgery, Computer-Assisted | 1 | 2017 | 76 | 0.030 |
Why?
| Neoplasm Seeding | 1 | 1996 | 7 | 0.030 |
Why?
| Cystic Duct | 1 | 1996 | 4 | 0.030 |
Why?
| Gastric Fistula | 1 | 1996 | 9 | 0.030 |
Why?
| Tissue Banks | 1 | 2016 | 18 | 0.030 |
Why?
| Cutaneous Fistula | 1 | 1996 | 13 | 0.030 |
Why?
| Intestinal Fistula | 1 | 1996 | 15 | 0.030 |
Why?
| Fasciitis, Necrotizing | 1 | 1996 | 15 | 0.030 |
Why?
| Prevalence | 2 | 2015 | 2540 | 0.030 |
Why?
| Foreign-Body Migration | 1 | 1996 | 35 | 0.030 |
Why?
| Digestive System | 1 | 1995 | 29 | 0.030 |
Why?
| Iopamidol | 1 | 1995 | 14 | 0.030 |
Why?
| Longitudinal Studies | 2 | 2015 | 2668 | 0.030 |
Why?
| Diatrizoate Meglumine | 1 | 1995 | 5 | 0.030 |
Why?
| Survival Rate | 1 | 2000 | 1884 | 0.030 |
Why?
| Image-Guided Biopsy | 1 | 2015 | 37 | 0.030 |
Why?
| Decision Trees | 1 | 2015 | 90 | 0.030 |
Why?
| Weight Reduction Programs | 1 | 2017 | 107 | 0.030 |
Why?
| Peritonitis | 1 | 1996 | 81 | 0.030 |
Why?
| Osmolar Concentration | 1 | 1995 | 166 | 0.030 |
Why?
| Child, Preschool | 2 | 2022 | 10457 | 0.030 |
Why?
| Markov Chains | 1 | 2015 | 124 | 0.030 |
Why?
| Netherlands | 1 | 2015 | 77 | 0.030 |
Why?
| Quality-Adjusted Life Years | 1 | 2015 | 116 | 0.030 |
Why?
| Behavior Therapy | 1 | 2017 | 236 | 0.030 |
Why?
| Patient Care Team | 1 | 2000 | 605 | 0.030 |
Why?
| Patient Reported Outcome Measures | 1 | 2019 | 359 | 0.030 |
Why?
| Costs and Cost Analysis | 1 | 2015 | 211 | 0.030 |
Why?
| Magnetic Resonance Imaging | 1 | 2006 | 3348 | 0.030 |
Why?
| Electronic Health Records | 1 | 2022 | 966 | 0.030 |
Why?
| Lipids | 1 | 2018 | 614 | 0.030 |
Why?
| Clinical Protocols | 1 | 2016 | 255 | 0.030 |
Why?
| Incidental Findings | 1 | 2015 | 80 | 0.030 |
Why?
| Confidence Intervals | 1 | 2015 | 318 | 0.030 |
Why?
| Outpatient Clinics, Hospital | 1 | 2014 | 84 | 0.030 |
Why?
| Consensus | 1 | 2017 | 644 | 0.030 |
Why?
| Enteral Nutrition | 1 | 1995 | 186 | 0.030 |
Why?
| Advisory Committees | 1 | 2015 | 231 | 0.030 |
Why?
| Monitoring, Physiologic | 1 | 1995 | 265 | 0.030 |
Why?
| ROC Curve | 1 | 2015 | 500 | 0.030 |
Why?
| Patient Participation | 1 | 2017 | 402 | 0.030 |
Why?
| Health Status Indicators | 1 | 2014 | 168 | 0.030 |
Why?
| Socioeconomic Factors | 1 | 2017 | 1192 | 0.030 |
Why?
| Medicaid | 1 | 2017 | 445 | 0.030 |
Why?
| Intensive Care Units | 1 | 2018 | 730 | 0.030 |
Why?
| Patient Selection | 1 | 2017 | 671 | 0.030 |
Why?
| Program Evaluation | 1 | 2017 | 868 | 0.030 |
Why?
| Sphincter of Oddi | 1 | 2012 | 5 | 0.030 |
Why?
| Radio Waves | 2 | 2003 | 17 | 0.030 |
Why?
| Evidence-Based Medicine | 1 | 2017 | 729 | 0.030 |
Why?
| Colic | 1 | 1992 | 7 | 0.030 |
Why?
| Mediastinum | 1 | 2012 | 23 | 0.030 |
Why?
| Esophagitis | 1 | 2013 | 66 | 0.030 |
Why?
| Adenoma, Villous | 1 | 2012 | 2 | 0.020 |
Why?
| Cost-Benefit Analysis | 1 | 2015 | 615 | 0.020 |
Why?
| Mucous Membrane | 1 | 2013 | 122 | 0.020 |
Why?
| Palliative Care | 1 | 2019 | 712 | 0.020 |
Why?
| Medicare | 1 | 2017 | 734 | 0.020 |
Why?
| Decision Support Techniques | 1 | 2015 | 387 | 0.020 |
Why?
| Anesthetics, Intravenous | 1 | 2011 | 39 | 0.020 |
Why?
| Injections, Intravenous | 1 | 2011 | 200 | 0.020 |
Why?
| Heartburn | 2 | 2001 | 12 | 0.020 |
Why?
| Blood Pressure | 1 | 2018 | 1743 | 0.020 |
Why?
| Edema | 1 | 2011 | 127 | 0.020 |
Why?
| Polyethylene | 1 | 2010 | 10 | 0.020 |
Why?
| Body Height | 1 | 1991 | 191 | 0.020 |
Why?
| Preoperative Care | 1 | 1992 | 343 | 0.020 |
Why?
| Gastroscopes | 1 | 2010 | 3 | 0.020 |
Why?
| Esophageal pH Monitoring | 1 | 2010 | 23 | 0.020 |
Why?
| Epithelium | 1 | 2011 | 312 | 0.020 |
Why?
| Duodenoscopy | 1 | 2009 | 7 | 0.020 |
Why?
| Methods | 1 | 1989 | 63 | 0.020 |
Why?
| Diet | 1 | 2017 | 1205 | 0.020 |
Why?
| Punctures | 1 | 1989 | 40 | 0.020 |
Why?
| Hydrogen-Ion Concentration | 2 | 2001 | 542 | 0.020 |
Why?
| Radiography | 1 | 1992 | 863 | 0.020 |
Why?
| Injections | 1 | 2010 | 174 | 0.020 |
Why?
| Reference Values | 1 | 1991 | 791 | 0.020 |
Why?
| Psychiatric Status Rating Scales | 1 | 1991 | 525 | 0.020 |
Why?
| Adenocarcinoma, Papillary | 1 | 2009 | 11 | 0.020 |
Why?
| Proto-Oncogene Proteins c-kit | 1 | 2009 | 65 | 0.020 |
Why?
| Kaplan-Meier Estimate | 1 | 2011 | 861 | 0.020 |
Why?
| Light | 1 | 2011 | 355 | 0.020 |
Why?
| Nervous System Diseases | 1 | 1991 | 260 | 0.020 |
Why?
| Age Distribution | 1 | 2009 | 376 | 0.020 |
Why?
| Sex Distribution | 1 | 2009 | 357 | 0.020 |
Why?
| Radiopharmaceuticals | 1 | 2008 | 167 | 0.020 |
Why?
| Fluorodeoxyglucose F18 | 1 | 2008 | 127 | 0.020 |
Why?
| ras Proteins | 1 | 2009 | 150 | 0.020 |
Why?
| Muscle Contraction | 1 | 1991 | 426 | 0.020 |
Why?
| Specimen Handling | 1 | 2009 | 163 | 0.020 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 264 | 0.020 |
Why?
| Age Factors | 1 | 2015 | 3133 | 0.020 |
Why?
| Intraoperative Complications | 1 | 2008 | 133 | 0.020 |
Why?
| Decision Making | 1 | 2014 | 837 | 0.020 |
Why?
| Safety Management | 1 | 2007 | 116 | 0.020 |
Why?
| Early Diagnosis | 1 | 2008 | 232 | 0.020 |
Why?
| Cell Transformation, Neoplastic | 1 | 2009 | 322 | 0.020 |
Why?
| Exercise | 1 | 2017 | 1923 | 0.020 |
Why?
| Survival Analysis | 1 | 2009 | 1282 | 0.020 |
Why?
| Thoracic Surgery | 1 | 2008 | 133 | 0.020 |
Why?
| Cross-Sectional Studies | 2 | 2008 | 5032 | 0.020 |
Why?
| Analysis of Variance | 1 | 2008 | 1283 | 0.020 |
Why?
| Proto-Oncogene Proteins | 1 | 2009 | 636 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2009 | 1694 | 0.010 |
Why?
| Comorbidity | 1 | 2009 | 1542 | 0.010 |
Why?
| Infant | 1 | 2018 | 8994 | 0.010 |
Why?
| Personnel Staffing and Scheduling | 1 | 2004 | 89 | 0.010 |
Why?
| Child | 2 | 2018 | 20824 | 0.010 |
Why?
| Sex Factors | 1 | 2009 | 1947 | 0.010 |
Why?
| False Negative Reactions | 1 | 2002 | 51 | 0.010 |
Why?
| Reoperation | 2 | 1996 | 555 | 0.010 |
Why?
| Gastric Acidity Determination | 1 | 2002 | 7 | 0.010 |
Why?
| Attitude of Health Personnel | 1 | 2009 | 1090 | 0.010 |
Why?
| Energy Transfer | 1 | 2001 | 51 | 0.010 |
Why?
| Cholangiocarcinoma | 1 | 2001 | 76 | 0.010 |
Why?
| Computer Simulation | 1 | 2004 | 943 | 0.010 |
Why?
| Equipment Failure | 1 | 1998 | 112 | 0.010 |
Why?
| Safety | 1 | 1998 | 325 | 0.010 |
Why?
| Radiology, Interventional | 1 | 1996 | 31 | 0.010 |
Why?
| Oximetry | 1 | 1995 | 86 | 0.010 |
Why?
| Blood Pressure Determination | 1 | 1995 | 150 | 0.010 |
Why?
| Technetium Tc 99m Disofenin | 1 | 1992 | 3 | 0.010 |
Why?
| Sincalide | 1 | 1992 | 5 | 0.010 |
Why?
| Organotechnetium Compounds | 1 | 1992 | 10 | 0.010 |
Why?
| Imino Acids | 1 | 1992 | 5 | 0.010 |
Why?
| Gallbladder | 1 | 1992 | 17 | 0.010 |
Why?
| Electrocardiography | 1 | 1995 | 602 | 0.010 |
Why?
| Radionuclide Imaging | 1 | 1992 | 126 | 0.010 |
Why?
| Aniline Compounds | 1 | 1992 | 95 | 0.010 |
Why?
| Glycine | 1 | 1992 | 162 | 0.010 |
Why?
| Chronic Disease | 1 | 1995 | 1715 | 0.010 |
Why?
| Pregnancy | 1 | 2001 | 6247 | 0.000 |
Why?
|
|
Edmundowicz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|